Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.
about
Music in disorders of consciousnessRelationship between oscillatory activity in the cortico-basal ganglia network and parkinsonism in MPTP-treated monkeys.Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.Daytime REM sleep in Parkinson's disease.Nocturnal sleep enhances working memory training in Parkinson's disease but not Lewy body dementia.Nocturia and overnight polysomnography in Parkinson disease.Sleep and impulsivity in Parkinson's diseaseFluctuations in cognition and alertness vary independently in dementia with Lewy bodies.Treatment of the sleep disorders associated with Parkinson's diseaseEvaluating and Managing Sleep Disorders in the Parkinson's Disease Clinic.Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.Sleepiness and Depression in Parkinson's Disease Patients Treated with Ropinirole and Levodopa.Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.Cortical Phase-Amplitude Coupling in a Progressive Model of Parkinsonism in Nonhuman Primates.Evaluation of cutoff scores for the Parkinson's disease sleep scale-2.Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis.Changes in Parkinson's disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson's disease.
P2860
Q30365220-78393A2C-81FB-4B7C-89B7-DA41508FA3EFQ30611028-C2819310-7102-4ECD-ADA2-5C09F5F9120DQ33832153-BF0407AC-179F-40B5-8775-20FE44E720FAQ36451550-65CA24DF-48A6-4FCE-95F2-C475E0A2EFBAQ36623413-951129A9-CE16-4AC2-ACEA-D68BD1DAFD40Q37255541-F98BA765-6498-4C11-B957-0725EBD24BF0Q37425362-E36D2B98-F0BA-45F1-AFBD-B3085CF2FE1BQ37625282-BB6ED679-CEA3-47C1-890E-4CE6CB4D8683Q38165855-62E7FC78-5054-4E01-AFDE-3566A975EC6BQ39000540-FDD91927-31C3-46AB-A946-95C176646050Q39085391-B21EC3AA-E5EC-48FB-A03B-34BDD635D202Q41675120-867820E1-F20E-4290-B99E-3D080E6A4008Q45238296-55727FDB-7B70-49D7-8230-6CA160F32C4CQ47658617-0B2773A9-AF83-4C45-B984-8851C089033CQ48016279-B7FCA9EB-0DE6-44CC-95C1-F6517C3ED593Q53397173-270B2E06-C966-4681-94E4-CC5A1DA818F1Q54968708-89CE481E-90AE-4C9E-9062-7EA94D76B5B0
P2860
Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Daytime alertness in Parkinson ...... vergent effects by drug class.
@ast
Daytime alertness in Parkinson ...... vergent effects by drug class.
@en
type
label
Daytime alertness in Parkinson ...... vergent effects by drug class.
@ast
Daytime alertness in Parkinson ...... vergent effects by drug class.
@en
prefLabel
Daytime alertness in Parkinson ...... vergent effects by drug class.
@ast
Daytime alertness in Parkinson ...... vergent effects by drug class.
@en
P2093
P2860
P356
P1433
P1476
Daytime alertness in Parkinson ...... vergent effects by drug class.
@en
P2093
Alan Freeman
Anthony G Wilson
Cathy Wood-Siverio
David B Rye
Donald L Bliwise
Jorge J Juncos
Lynn Marie Trotti
Sophia A Greer
P2860
P304
P356
10.1002/MDS.25082
P407
P577
2012-07-02T00:00:00Z